BridGene Biosciences Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $12M
Latest Deal Amount
  • Investors
  • 5

BridGene Biosciences General Information

Description

Developer of innovative and small molecules intended to drug traditionally undruggable targets. The company combines technologies including covalent chemistry, chemical proteomics, and quantitative mass spectrometry to discover novel targets, develop therapeutics and covalent small-molecule inhibitors, enabling the healthcare industry to treat diseases, with targets previously inaccessible to small molecules.

Contact Information

Website
www.bridgenebio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 75 Nicholson Lane
  • San Jose, CA 95134
  • United States
+1 (408) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BridGene Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 05-May-2021 $12M 0000 Completed Generating Revenue
2. Early Stage VC Completed Startup
1. Grant 01-Jan-2018 $223K Completed Startup
To view BridGene Biosciences’s complete valuation and funding history, request access »

BridGene Biosciences Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

BridGene Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3128084-A1 Fgfr inhibitors for the treatment of cancer Pending 14-Feb-2019 000000000

BridGene Biosciences Executive Team (3)

Name Title Board Seat Contact Info
Ping Cao Ph.D Co-Founder & Chief Executive Officer
Irene Yuan Co-Founder & Executive Vice President
Chao Zhang Ph.D Scientific Co-Founder & Chairman of Scientific Advisory Board
To view BridGene Biosciences’s complete executive team members history, request access »

BridGene Biosciences Board Members (1)

Name Representing Role Since
Chao Zhang Ph.D BridGene Biosciences Scientific Co-Founder & Chairman of Scientific Advisory Board 000 0000
To view BridGene Biosciences’s complete board members history, request access »

BridGene Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BridGene Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kaitai Capital Venture Capital Minority 000 0000 000000 0
Pangu Venture Venture Capital Minority 000 0000 000000 0
Takeda Ventures Corporate Venture Capital Minority 000 0000 000000 0
Wedo Venture Partners Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view BridGene Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial